ArticleJournal for immunotherapy of cancer2024

Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series.

Catriona Harvey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.